Shari Meyers received her Ph.D. degree from the Department of Microbiology at the University of Texas, Austin, Tex, USA for her work in the Laboratory of Dr. Jacqueline Dudley. Following graduation, Dr. Meyers became a postdoctoral fellow at St. Jude Children’s Research Hospital in the Department of Tumor Cell Biology in which she worked with Dr. Scott Hiebert to understand the function of the chimric protein product, RUNX1/ETO, produced as a result of the translocation (8:21) associated with acute myeloid leukemias. Dr. Meyers identified RUNX1 as a site-specific DNA binding protein and transcriptional activator and showed that RUNX1/ETO could repress transcription at RUNX1-regulated promoters. In 1996, Dr. Meyers joined the Department of Biochemistry and Molecular Biology and the Feist-Weiller Cancer Center at Louisiana State University Health Sciences Center in Shreveport, La, USA where she is presently an Associate Professor. Dr. Meyers has continued her research focus on transcriptional regulation in cancer, conducting studies on the RUNX and Gfi-1 families of transcription factors and the corepressors ETO (MTG8) and related proteins. She has published numerous studies concerning transcriptional regulation in leukemia and, more recently, prostate and ovarian cancer.
Biography Updated on 22 June 2010